SERPINB3 and metabolic dysfunction-associated steatohepatitis: To further investigate the role of SerpinB3 in NASH progression, in the present study we have investigated a novel therapeutic strategy for the treatment of NASH using 1-Piperidine Propionic Acid (1-PPA), a small molecule patented and proposed as SerpinB3 inhibitor [28,29].